Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes — Piero Ruggenenti (2010) | RDL Network
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes
Article 2010 en
Authors
PR
Piero Ruggenenti
DC
Dario Cattaneo
SR
Stefano Rota
Abstract
1 min read
Adding ezetimibe to simvastatin therapy helps to improve the pro-atherogenic lipoprotein profile in type 2 diabetic patients who fail to reach recommended lipid targets with statin therapy alone.
Eeva Sliz, Johannes Kettunen, Michael V. Holmes, Clare Oliver Williams, Charles Boachie, Qin Wang, Minna Männikkö, Sylvain Sebért, Robin Walters, Kuang Lin, Iona Y. Millwood, Robert B. Clarke, Liming Li, Naomi Rankin, Paul Welsh, Christian Delles, J. Wouter Jukema, Stella Trompet, Ian Ford, Markus Perola, Veikko Salomaa, Paul M Ridker, Zhengming Chen, Debbie A. Lawlor,
Eeva Sliz, Johannes Kettunen, Michael V. Holmes, Clare Oliver‐Williams, Charles Boachie, Qin Wang, Minna Männikkö, Sylvain Sebért, Robin Walters, Kuang Lin, Iona Y. Millwood, Robert B. Clarke, Liming Li, Naomi Rankin, Paul Welsh, Christian Delles, J. Wouter Jukema, Stella Trompet, Ian Ford, Markus Perola, Veikko Salomaa, Paul M Ridker, Zhengming Chen, Debbie A. Lawlor,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.